Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Alexander M.,,Editorial: RANKL links arterial calcification with osteolysis,2009,Circulation Research,16,10.1161/CIRCRESAHA.109.198010,United Kingdom,Editorial,Manchester,1,Journal,2-s2.0-66149102000
Panizo S.,,RANKL increases vascular smooth muscle cell calcification through a rank-bmp4-dependent pathway,2009,Circulation Research,174,10.1161/CIRCRESAHA.108.189001,Spain;Spain,Article,Lleida;Lleida,1,Journal,2-s2.0-66149095438
Helas S.,,Inhibition of receptor activator of NF-κB ligand by denosumab attenuates vascular calcium deposition in mice,2009,American Journal of Pathology,103,10.2353/ajpath.2009.080957,Germany;Germany,Article,Dresden;Dresden,0,Journal,2-s2.0-68449102008
Styrkarsdottir U.,,Multiple genetic loci for bone mineral density and fractures,2008,New England Journal of Medicine,455,10.1056/NEJMoa0801197,Iceland,Article,Reykjavik,0,Journal,2-s2.0-44349167229
Richards J.,,"Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study",2008,The Lancet,493,10.1016/S0140-6736(08)60599-1,United Kingdom,Article,London,0,Journal,2-s2.0-43049181624
Kim J.,,"Association between osteoprotegerin (OPG), receptor activator of nuclear factor-κB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women",2007,Menopause,91,10.1097/gme.0b013e31802d976f,South Korea;South Korea,Article,Gyeong Ju;Seoul,0,Journal,2-s2.0-34948883973
Kiechl S.,,Soluble receptor activator of nuclear factor-κB ligand and risk for cardiovascular disease,2007,Circulation,92,10.1161/CIRCULATIONAHA.106.686774,Austria,Article,Innsbruck,1,Journal,2-s2.0-34547574967
Hofbauer L.,,Vascular calcification and osteoporosis - From clinical observation towards molecular understanding,2007,Osteoporosis International,177,10.1007/s00198-006-0282-z,Germany,Review,Marburg,0,Journal,2-s2.0-33846903357
El-Abbadi M.,,Mechanisms of Vascular Calcification,2007,Advances in Chronic Kidney Disease,77,10.1053/j.ackd.2006.10.007,United States,Article,Seattle,0,Journal,2-s2.0-33845761076
Rhee E.J.,,The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease,2006,Metabolism: Clinical and Experimental,60,10.1016/j.metabol.2006.05.020,South Korea,Article,Suwon,0,Journal,2-s2.0-33748454417
Imamura A.,,Klotho gene polymorphism may be a genetic risk factor for atherosclerotic coronary artery disease but not for vasospastic angina in Japanese,2006,Clinica Chimica Acta,48,10.1016/j.cca.2006.02.021,Japan,Article,Nagoya,0,Journal,2-s2.0-33746704926
Rhee E.J.,,The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans,2006,Clinical Endocrinology,19,10.1111/j.1365-2265.2006.02530.x,South Korea,Article,Jongno-gu,0,Journal,2-s2.0-33646827019
Hsu Y.,,Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men,2006,Human Genetics,92,10.1007/s00439-005-0062-4,United States,Article,Boston,0,Journal,2-s2.0-29244488577
Taylor B.,,Matrix Gla protein and osteopontin genetic associations with coronary artery calcification and bone density: The CARDIA study,2005,Human Genetics,39,10.1007/s00439-005-1258-3,United States;United States,Article,Minneapolis;Minneapolis,0,Journal,2-s2.0-21444451164
Collin-Osdoby P.,,Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin,2004,Circulation Research,362,10.1161/01.RES.0000149165.99974.12,United States,Review,St. Louis,1,Journal,2-s2.0-9344246863
Soufi M.,,Osteoprotegerin gene polymorphisms in men with coronary artery disease,2004,Journal of Clinical Endocrinology and Metabolism,81,10.1210/jc.2003-032054,Germany,Article,Marburg,1,Journal,2-s2.0-4043110456
Hofbauer L.,,Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases,2004,Journal of the American Medical Association,727,10.1001/jama.292.4.490,Germany,Review,Marburg,0,Journal,2-s2.0-3242781731
Kiechl S.,,Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease,2004,Circulation,430,10.1161/01.CIR.0000127957.43874.BB,Austria,Article,Innsbruck,1,Journal,2-s2.0-2442492972
Schett G.,,Soluble RANKL and Risk of Nontraumatic Fracture,2004,Journal of the American Medical Association,119,10.1001/jama.291.9.1108,Austria,Article,Vienna,1,Journal,2-s2.0-10744223478
Schäfer C.,,The serum protein α<inf>2</inf>-Heremans-Schmid glycoprotein/ fetuin-A is a systemically acting inhibitor of ectopic calcification,2003,Journal of Clinical Investigation,721,10.1172/JCI17202,Germany,Article,Aachen,1,Journal,2-s2.0-85047694301
Kawano K.i.,,Klotho gene polymorphisms associated with bone density of aged postmenopausal women,2002,Journal of Bone and Mineral Research,145,10.1359/jbmr.2002.17.10.1744,Japan,Article,Tokyo,0,Journal,2-s2.0-0036785320
Li J.,,Aortic calcification on plain chest radiography increases risk for coronary artery disease,2002,Chest,48,10.1378/chest.121.5.1468,United States,Article,Cambridge,0,Journal,2-s2.0-0036257150
Brändström H.,,A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function,2002,Biochemical and Biophysical Research Communications,60,10.1016/S0006-291X(02)00137-7,Sweden,Article,Uppsala,0,Journal,2-s2.0-0036289256
Langdahl B.L.,,Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures,2002,Journal of Bone and Mineral Research,170,10.1359/jbmr.2002.17.7.1245,Denmark,Article,Aarhus,1,Journal,2-s2.0-0035991255
Iribarren C.,,"Calcification of the aortic arch: Risk factors and association with coronary heart disease, stroke, and peripheral vascular disease",2000,Journal of the American Medical Association,336,10.1001/jama.283.21.2810,United States;United States,Article,San Francisco;Oakland,1,Journal,2-s2.0-0034616810
Burgess T.L.,,The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts,1999,Journal of Cell Biology,574,10.1083/jcb.145.3.527,United States,Article,Thousand Oaks,1,Journal,2-s2.0-0033519221
Hsu H.,,Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand,1999,Proceedings of the National Academy of Sciences of the United States of America,1332,10.1073/pnas.96.7.3540,United States,Article,Thousand Oaks,1,Journal,2-s2.0-13044316551
Kong Y.Y.,,"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis",1999,Nature,2606,10.1038/16852,Canada,Article,Toronto,0,Journal,2-s2.0-0033611467
Yano K.,,Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: Increased serum concentrations in postmenopausal women with osteoporosis,1999,Journal of Bone and Mineral Research,340,10.1359/jbmr.1999.14.4.518,Japan,Article,Shinjuku,1,Journal,2-s2.0-0033026628
Bucay N.,,Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification,1998,Genes and Development,1959,10.1101/gad.12.9.1260,United States,Article,Thousand Oaks,1,Journal,2-s2.0-0032079445
Lacey D.L.,,Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation,1998,Cell,4250,10.1016/S0092-8674(00)81569-X,United States,Article,Thousand Oaks,1,Journal,2-s2.0-0032540319
Yasuda H.,,Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL,1998,Proceedings of the National Academy of Sciences of the United States of America,3287,10.1073/pnas.95.7.3597,Japan,Article,Shinjuku,1,Journal,2-s2.0-0032584208
Kuro-o M.,,Mutation of the mouse klotho gene leads to a syndrome resembling ageing,1997,Nature,2295,10.1038/36285,Japan,Article,Kodaira,0,Journal,2-s2.0-0030724491
Simonet W.S.,,Osteoprotegerin: A novel secreted protein involved in the regulation of bone density,1997,Cell,3955,10.1016/S0092-8674(00)80209-3,United States,Article,Thousand Oaks,1,Journal,2-s2.0-0031005576
Danielsen R.,,Predominance of aortic calcification as an atherosclerotic manifestation in women: The Reykjavík study,1996,Journal of Clinical Epidemiology,48,10.1016/0895-4356(95)00547-1,Iceland,Article,Reykjavik,0,Journal,2-s2.0-0029873702
Witteman J.,,Aortic calcified plaques and cardiovascular disease (the Framingham study),1990,The American Journal of Cardiology,198,10.1016/0002-9149(90)90505-U,Netherlands;United States;United States,Article,Rotterdam;Boston;Boston,0,Journal,2-s2.0-0025109753
Witteman J.,,AORTIC CALCIFICATION AS A PREDICTOR OF CARDIOVASCULAR MORTALITY,1986,The Lancet,240,10.1016/S0140-6736(86)90530-1,Netherlands,Article,Rotterdam,0,Journal,2-s2.0-0023019674
Boukhris R.,,Calcification of the Aorta and Osteoporosis: A Roentgenographic Study,1972,JAMA: The Journal of the American Medical Association,100,10.1001/jama.1972.03190360019005,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-0015495558
